With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Selective inhibition of nuclear export as a novel therapeutic strategy in AML||Dana-Farber Cancer Institute / Julia Etchin||Young Investigator Grants||2012||Massachusetts|
|Investigating the Role of the RNA Binding Protein LIN28 in Neuroblastoma||Boston Children's Hospital / John Powers||Young Investigator Grants||2012||Massachusetts|
|In-UTR mutations in neuroblastoma: Functional consequences and therapeutic implications||Children's Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD||Innovation Grants||2012||Pennsylvania|
|Targeting Neovascularization in Graft-Versus-Host Disease||Memorial Sloan-Kettering Cancer Center / Marcel van den Brink, MD/PhD||Innovation Grants||2012||New York|
|Modeling Pediatric Leukemia in the Zebrafish to Enable Discovery of New Anti-Leukemic Compounds||University of California, San Diego / David Traver, MD||Innovation Grants||2012||California|
|Identification and validation of new therapeutic targets in pediatric leukemia through an aneuploidy-based synthetic lethality screen||Dana-Farber Cancer Institute / David Pellman, MD||Innovation Grants||2012||Massachusetts|
|Identification of predisposition genes for Ewing sarcoma segregating in high-risk pedigrees||Huntsman Cancer Institute / Lisa Cannon-Albright, PhD||Innovation Grants||2012||Utah|
|A novel mouse model of rhabdomyosarcoma||Vanderbilt University Medical Center / Chin Chiang, PhD||Innovation Grants||2012||Tennessee|
|Casein Kinase 1 alpha Agonists as Novel Medulloblastoma Inhibitors||University of Miami Miller School of Medicine / David Robbins, PhD||Innovation Grants||2012||Florida|
|V alpha-invariant NKT cells as a novel platform for cancer immunotherapy||Baylor College of Medicine / Leonid Metelitsa, MD, PhD||Innovation Grants||2012||Texas|